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Diabetes is caused by the loss or dysfunction of insulin-secreting b-cells in the pancreas. b-cells reduce their
mass and lose insulin-producing ability in vitro, likely due to insufficient cell-cell and cell-extracellular
matrix (ECM) interactions as b-cells lose their native microenvironment. Herein, we built an ex-vivo cell
microenvironment by culturing primary b-cells in direct contact with ‘synthetic neighbors’, cell-sized soft
polymer microbeads that were modified with cell-cell signaling factors as well as components from
pancreatic-tissue-specific ECMs. This biomimetic 3D microenvironment was able to promote native
cell-cellandcell-ECMinteractions.Weobtainedsustainedmaintenanceofb-cellfunctioninvitroenhanced
cell viability from the few days usually observed in 2D culture to periods exceeding three weeks, with
enhanced b-cell stability and insulin production. Our approach can be extended to create a general 3D
culture platform for other cell types.
C
ellsexistinvivowithin thecomplexmicroenvironment thatmakesuptheirnativetissue,fromwhichthey
receive a continuous supply of nutrients and to which they release waste; they undergo tissue-specific
interactions and signaling with extracellular matrix (ECM) components and communication with neigh-
boringcells
1–3.Currentinvitrocellcultureremovescellsfromtheirnativetissuecontextandplacesthemona2D
surface in culture flasks, which can disrupt these interactions and induce changes in gene expression and cellular
phenotype
1. In order to address these limitations, researchers have investigated different approaches to 3D cell
culture using biocompatible materials for microencapsulation, microparticles or cell-laden hydrogels modified
with ECM proteins
4–7 with improved function
8–10; however, even the most advanced in vitro 3D culture
approaches lack important features needed to reconstitute their in vivo counterparts.
Theb-cellsinthepancreaticisletsregulatetheirsecretionofinsulininresponsetoglucoselevelsinthebloodto
maintain glucose homeostasis in the body. In the islets, b-cells occupy over 60% percent of the total volume
11.
Direct contact between cells and cell–cell interactions are important for many cellular activities to maintain
survival and function of b-cells
12–14, including intracellular signaling. Recently, Konstantinova et al. showed that
b-cellscommunicateviaEphAreceptorsandEphrinAligands
15.Basedonthisfinding,theAnsethgroupachieved
better survival and insulin secretion of b-cells over ten days by encapsulating the cells into EphA–EphrinA and
cell-adhesive peptide (RGD) functionalized poly(ethylene glycol) (PEG) hydrogels
16. However, encapsulation of
cells within hydrogels may lead to cell death due to diffusional limitations in oxygen supply and nutrients
17.
Furthermore, exposure of cells to the harsh chemical (i.e. pH change, or high ion concentration) or physical (UV
irradiation) environments used during many encapsulation processes is cytotoxic and may affect cellular activ-
ity
18. A challenge is that traditional bulk homogeneous hydrogel constructs cannot provide a truly 3D envir-
onment that effectively replaces cell-cell interactions.
Herein, we propose a new strategy for engineering an ex vivo 3D microenvironment for studying the stability
andfunctionofpancreaticb-cellsforwhichmicrogelsaredesignedas‘‘syntheticneighbors’’capableofpresenting
ligand, and replicating aspects of the cell-cell interactions between beta cells in a crowded cell environment such
as the pancreas. Our goal is to build an artificial 3D home for b-cells that can thus recapitulate the native tissue
conditions in pancreatic islets. Specifically, as shown in Figure 1, b-cells are cultured in direct contact with soft
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These microbeads are made from crosslinked poly(ethylene glycol)-
co-poly-L-lysine (PEG-co-PLL) hydrogels modified with the cell
surface receptor and its membrane-bound ligand pair, EphA/
EphrinA, and coated with pancreatic tissue specific ECM compo-
nents derived from rat pancreatic decellularized matrix. In contrast
todirect cell encapsulation inPEGgels, wecan place b-cells together
withmicrobeadstocreatea3Dcultureconditioninwhichtheb-cells
are surrounded by synthetic neighbor cells that present the key
ligands and receptors needed for cell-cell communication as well as
appropriate matrix. Furthermore, because cells are not fixed in the
hydrogel networks, they have more freedom to interact with neigh-
boring cells, as wellas to migrate and interact with the surface recep-
tor or ECM components on the surfaces of the microbeads.
PEG hydrogels are widely used for biomedical applications due to
their biocompatibility, high permeability to small molecules, as well
as tunable stiffness and chemical compositions. Biofunctional pep-
tides or proteins can be easily introduced to the hydrogel network
(i.e. by covalent bonding or copolymerization) while maintaining
its general material properties
18. We chose PEG-co-PLL polymer
hydrogels as our starting material. Cell-adhesive peptides such as
RGD and other fibronectin domains, and cell surface receptors
EphA/EphrinA have both previously been successfully conjugated
intoplainPEGhydrogelsforb-cellencapsulation
16.Inourapproach,
the copolymerization of PLL with PEG introduces positive charges
on the gel surface, which allows for the absorption of ECM compo-
nents from pancreatic tissue and provides a handle for receptor
conjugation to the gel surface.
Single purified ECM proteins or combinations of various proteins
(i.e. collagens, fibronectin, growth factors or laminin, etc.) have been
used to modify cell culture substrates to mimic cell-ECM interac-
tions
5,7,19,20. Cell-derived matrix coatings from fibroblasts
21–25 and
Matrigel
TM 26 have also been applied to promote cell attachment
and improve cell functions. However, these surfaces are not able to
recapitulate thecomplexityofthenativemicroenvironment interms
of the tissue-specific combinations of various ECM components.
Recently, decellularization procedures have been optimized to
remove cellular components from specific tissues while preserving
key molecular components in the ECM
27–29. Decellularized matrix
(DCM) from liver tissue has been developed for 3D culture of hepa-
tocytes and was shown to considerably improve cell viability and
proliferation
30. Other types of DCM from various tissues and whole
organs have also been reported
28,31,32. Based on these findings, we
hypothesize that absorption of pancreatic DCM components onto
the microbeads could similarly emulate the tissue specific native
microenvironment for b-cells.
The PEG-co-PLL microbeads were prepared by microfluidic
emulsification and UV-polymerization
33–35, which provides precise
controlovertheirsizeandchemicalcomposition.b-cellsarecultured
in direct contact with microbeads, which not only mimic the in vivo
presentation of cells in the pancreatic islets, but also overcome the
diffusion limitations of oxygen and nutrients, as mass transfer can
moreeasilybeachievedthroughthevoidspacesbetweenthecellsand
microbeads. Thus, these systems allow the generation of 3D assem-
bliesof functional cells such asb-cells with microgel cell mimics that
maintain key cell-cell communications and present components of
the native matrix. The result is the sustained maintenance of cell
function in vitro and prolonged cell survival. This concept of syn-
thetic ‘‘neighbors’’ is one that we anticipate can be adapted to the
maintenance of other functional cell types.
Results
Characterization of decellularization of pancreatic tissue. We
developed a method to decellularize rat pancreatic tissue by
perfusion with Triton X-100, a nonionic detergent that lyses cells
andsolubilizescytoplasmiccomponents.After48 hoursperfusion,a
translucent acellular tissue was formed (Figure 2a, b). Hematoxylin
and eosin (H&E) stain of the resulting tissue revealed no nuclei or
cytoplasmiccompartments(Figure2c).Thedecellularizedtissuewas
lyophilized forthree daysand milled topowder. Theinitial weight of
the pancreatic tissue from ten adult rats was approximately 65 g,
from which was obtained 68.6 mg of lyophilized DCM powder.
After 24 hours of pepsin digestion at 37uC, a nearly clear solution
of DCM was generated. DCM is a very complex composition of
biomolecules, including different types of collagen (type I, IV, etc.),
fibronectin, laminin, and other proteins and peptides
29,36. As shown
in the SDS-page image, the solubilized DCM exhibited the presence
of lower molecular weight bands similar to those in pancreatic tissue
(Figure 2e).
Microfluidic synthesisofPEG-co-PLL microbeadsand3Dculture
of b-cells. Free thiol groups were covalently linked onto fusion
Figure 1 | The schematic of microfluidic synthesis of PEG-co-PLL microbeads and 3D cell culture. A typical microfluidic flow-focusing droplet
generator was used to emulsify PEG-co-PLL aqueous pre-gel solution. The droplets were polymerized after flow through the extension channel and
exposuretoUVirradiationtoformsoftmicrobeads.Thesemicrobeads(inredcolor)weremodifiedwithdecellularizedmatrix(DCM)componentsfrom
pancreatic tissue, and cultured with b-cells (in green) in direct contact. The inset schematic shows the interface between the microbeads and their
neighboring cells. The shell (in dark yellow color) on the microbeads represents the DCM components from pancreatic tissue.
www.nature.com/scientificreports
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(Traut’s reagent)
16. Specifically, fusion proteins were dissolved in
PBS containing 2 mM EDTA. Traut’s reagent (10 mM/mL) was
mixed with the fusion protein solution (2 mM/mL) and reacted for
1 hour at room temperature. Excess Traut’s reagent was separated
from the solution using a desalting column. The pre-gel solution
comprises 8 wt% PEGDA (Mw 5 1000), 2 mg/mL PLL (Mw 5
15,000 , 30,000), 1 mM/mL thiolated EphA5-FC and EphrinA5-
Fc, and 0.5 wt% of photo-initiator HMPP. Thiolated proteins were
introduced to the PEG network through thiol-acrylate reactions
initiated by UV irradiation
37,38. PLL was incorporated into the PEG
hydrogel network by physical trapping to yield an interpenetrating
network,duetothefactthatthemoleculardimensionsofthePLLare
larger than the mesh size of the PEG gel network
7,22. The pre-gel
solution was injected into a microfluidic flow-focusing droplet
generator (Figure 3a)
39,40, from which the aqueous stream broke
into droplets in mineral oil with uniform sizes. The droplets were
partially polymerized for approximately 1 minute in the chip to
prevent aggregation, and then fully polymerized in the extension
tubing for about 4 minutes. The PEG hydrogel networks were
formed through two types of reactions: the free radical polymeri-
zation of PEG diacrylate and the linking of thiols with acrylate
groups
38. The size of the microbeads was 21 6 1 mm with a
monodispersity of 2.4% (Figure 3b,c). FITC-labeled PLL was used
toconfirmahomogeneousdistributionofentrappedPLLinthePEG
gel network. After the modification of the microbeads with the
adsorption of DCM components from aqueous solution, noticeable
changes in the size of microbeads were not observed.
Although this work focused on preparation of microbeads with
sizes similar to that of b-cells, the microfluidic reactor also can be
used to make microbeads with various sizes ranging from 15 to
85 mm.In general, the size of the microbeads is increased byincreas-
ingthevolumetricflowrate of thepre-gel solution(Figure 3d)
34.The
number of microbeads in each well was optimized to ensure that the
cells and microbeads could form a 3D densely packed structure
(Figure 3e). The cells were stained with calcein AM (green color,
indication of live cells) and Ethidium homodimer-1 (red color,
indicationofdeadcells)afterculturingwithmicrobeadsfortwodays
(shown in Figure 3f). We observed single cell, cell-cell cluster and
cell-microbead aggregates. Single cells maintained their spherical
shape, while cell clusters were observed to spread on the surface or
occupy the spaces between several microbeads.
Characterization of PEG-co-PLL microbeads. FT-IR spectrometry
was used to qualitatively characterize the chemical composition of
microbeads before and after modification of DCM (shown in
Figure 4a). PEG-co-PLL samples show combinations of absorption
peaks of C-O-C vibration at 1150 cm
21 (from PEG) and N-H
stretching at 3400–3250 cm
21 and bending at 1650 cm
21 (from
PLL). PEG-co-PLL 1 DCM show enhanced absorption of the C-H
stretching vibration at 2950–2850 cm
21,C 5O stretching vibration
at 1735 cm
21, N-H bending vibration at 1640 cm
21 and C-H bend-
ing vibration at 1470 and 1360 cm
21, mostly from different types of
collagen
41, which were found in the DCM spectra.
Figures4bandcshowtheSEMimagesoflyophilizedPEG-co-PLL
and PEG-co-PLL 1 DCM microbeads, respectively. Compared to
thesizeofthewetmicrobeads,thesizesofthelyophilizedmicrobeads
decreased from 21 mmt o1 5mm. No significant size difference was
observedforthesetwotypesofmicrobeads.Clumps/clustersofPEG-
co-PLL microbeads were formed during the freeze-drying process,
probably due to the crystallization of water in the polymer network.
In comparison, PEG-co-PLL 1 DCM microbeads exhibited much
less aggregation. Furthermore, the surface morphologies of PEG-co-
PLL and PEG-co-PLL 1 DCM microbeads are quite different after
lyophilization: PEG-co-PLL microbeads have a very smooth surface,
indicating the homogeneous structure of the hydrogel network;
PEG-co-PLL1DCMmicrobeads haveabumpyandheterogeneous
surface. This observation suggests that a thin shell of polymer
(mostly a mixture of collagen and other negatively charged proteins)
remainsadsorbedtothesurfaceofthePEG-co-PLLmicrobeadsafter
the modification with DCM.
Live/dead cell viability test on b-cells cultured with various types
of microbeads. b-cells were cultured with four types of PEG-co-PLL
microbeads, specifically, PEG-co-PLL microbeads (Beads only),
EphA/EphrinA fusion protein modified PEG-co-PLL Beads (Beads
Figure 2 | Decellularized matrix (DCM) from pancreatic tissue. (a) Rat pancreatic tissue was perfused in Triton X-100 aqueous solution.
(b)Decellularizedpancreatictissueafter48 hoursperfusion.(c)Hematoxylinandeosin(H&E)stainedsectionsofthedecellularizedpancreatictissue,as
theconfirmationoftheabsenceofcells.(d)PowderofDCMafterlyophilization.(e)SDS-PAGEofdigestedpancreatictissueandsolubilizedDCM.Note
that the pancreatic tissue has a more complex mixture of cellular and extracellular matrix components than DCM, while soluble DCM kept most lower
molecular weight bands. The scale bar is 1 cm in a and b, 200 mm in c, respectively.
www.nature.com/scientificreports
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(Beads 1 DCM), and EphA/EphrinA fusion protein modified PEG-
co-PLL Beads absorbed with DCM (Beads 1 EphA/EphrinA 1
DCM). Control experiments were carried out on cells plated in
regular polystyrene culture plates (non-coating). Cell viability at
days 2, 7 and 21 was tested using a Live/Dead viability/cytotoxicity
kit for from Invitrogen.
At day 2, we did not observe significant differences in cell viability
among all five conditions. Cells were evenly distributed on a poly-
styrenesubstrate(asacontrol)orinthemicrobeadsinthecellmedia
(as shown in Figure 3f). Fluorescent images were taken and used as
references for quantitative analysis. At day 7, we observed that
approximately 33% of cells cultured in the non-coated 2D microwell
control were not viable, while cells cultured with microbeads main-
tained over 90% survival for all four types of microbeads. Among
these types of microbeads, cells cultured in Beads 1 EphA/EphrinA
1 DCM showed the highest survival at 95%, which is slightly higher
than those in other three types of microbeads (not statistically sig-
nificant). Cells cultured on 2D substrates spread out on the surface,
whilecellsculturedin3Dmicrobeadsmaintaintheirsphericalshape.
Wealsoobservedthatcellclustersformedininthe3Dculture.Atday
21, only 14% of cells were viable in the uncoated 2D culture. For the
cells cultured in 3D with microbeads, we observed enhanced cell
viabilityof28%,17%,26%,and69%fortheconditionsofBeadsonly,
Beads 1 EphA/EphrinA, Beads 1 DCM, and Beads 1 EphA/
EphrinA 1 DCM, respectively. Most surviving cells were spherical
in shape, and some formed aggregations with cell-cell or cell-
microbead contacts. In the cells cultured with Beads 1 EphA/
EphrinA1DCM,weobservedlargepopulationsof3Dclusteraggre-
gates of b-cells and microbeads (shown in Figure 5c), comprised of
multiple live cells and a range of 5 to 40 microbeads.
Size distribution of the aggregates formed by b-cells with various
typesofmicrobeads.Aggregatesofcell/cellandcell/microbeadwere
observed in the first two to four days. Cells cultured on the 2D
polystyrene substrate (2D) spread out on the surface, while cells
cultured with microbeads primarily maintain spherical morpho-
logy. We analyzed the size distribution of cells and aggregates for
day 7 and day 21 (shown in Figure 6). Three size ranges used here
were 1–100, 100–400, and . 400 mm
2, representing single cell, small
aggregates, and large aggregates, respectively. At day 7, the average
cross-sectional areas of the aggregates under 3D conditions are
approximately 210 6 20 mm
2, which is slightly larger than that on
2Dsurface (170 6 20 mm
2). However, we did notobserve significant
differences among the cells cultured with four different microbead
conditions (3D). The size distributions of those aggregates are also
similarforthreerangeswith4562%in1–100 mm
2,3962%in100–
400 mm
2, and 16 6 2% in . 400 mm
2, respectively. At day 21,
compared to the cells cultured in 2D conditions, the cell
populations in the condition of Bead 1 EphA/EphrinA 1 DCM
have significantly fewer single cells, and more aggregates in the
size range of . 400 mm
2. For the other three 3D conditions (Beads
only,Beads1EphA/EphrinA,andBeads1DCM),wealsoobserved
this trend, but it was not substantial.
b-cell specific genes expression and glucose stimulated insulin
secretion (GSIS). Quantitative PCR (qPCR) was used to monitor
the expression of several important b-cell specific genes, specifically,
v-Maf musculoaponeurotic fibrosarcoma oncogene homologue A
(MafA), insulin 2 (Ins2), and pancreatic duodenal homeobox
factor (Pdx1). After 21 days b-cells cultured with Beads 1 EphA/
EphrinA 1 DCM have 19%, 68%, and 45% increased expression of
MafA, Ins2, and Pdx1 genes, respectively, over cells cultured on
Figure 3 | MicrofluidicsynthesisofPEG-co-PLLmicrobeadsand3Dcultureofpancreatic b-cells.(a)Typicalopticalmicroscopeimage ofmicrofluidic
generationofPEG-co-PLLdroplets.Mineraloilandpre-gelaqueoussolutionweresuppliedfromsidechannelsandcenterchannel,respectively.(b) Size
distribution of the PEG-co-PLL microbeads with mean diameter of 21 6 1 mm. (c) Polymerized PEG-co-PLL (with or without EphA/EphrinA
modification) microbeads were dispersed in solubilized DCM. (d) The size of PEG-co-PLL microbeads in response to the change of flow rates of pre-gel
solution.(e)Opticalmicroscopeimageofpancreaticb-cellsculturedwithPEG-co-PLLmicrobeadswitharatioofcellstomicrobeadsof153.Thenumber
of cells in each well of a 48-well plate was 1.2 3 10
5/well. (f) The optical fluorescent image of b-cells with microbeads at day 2, which indicated good
contact of cells with microbeads in a 3D manner. The cells were stained with calcein AM (green) and Ethidium homodimer-1 (red) for 30 minutes. The
scale bars in a, c, e, and f are 100 mm.
www.nature.com/scientificreports
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Beads, Beads 1 EphA/EphrinA, or Beads 1 DCM exhibited down
regulation for MafA, Ins2, and Pdx1 genes relative to TCPS cultured
cells,
255–
242%,
237–
223%, and
259–
251% respectively (Figure 7a).
The glucose stimulated insulin response (GSIS) for b-cells cultured
with Beads 1 EphA/EphrinA 1 DCM was significantly improved,
over 55% closer to baseline levels as compared to cells cultured on
TCPS only after one week. Improved GSIS for cells cultured with
Beads 1 EphA/EphrinA 1 DCM relative to TCPS was observed out
to 21 days. At 21 days b-cells grown on TCPS demonstrated a
negative response to high-glucose treatment, while those cultured
in contact with Beads 1 EphA/EphrinA 1 DCM retained a
positive response, secreting 40% more insulin when exposed to
high-glucose conditions. These results demonstrate the importance
of cell–cell contact and cell-matrix interactions and how these are
critical in maintaining normal glucose responsive insulin secretion.
Population change of b-cells in 2D and 3D conditions. To follow
the dynamics of the decline in b-cell population, the dissociated cells
were infected with two lentiviruses that express fluorescent proteins
helpful for visualization of b-cells (Figure 8, single fluorescent
channel images and bright-field images are included in Supplemen-
tary Information). Specifically, cells were engineered to express a
blue fluorescent protein constitutively and a red fluorescent
protein as a function of insulin promoter activity. As shown in
Figure 8a, approximately 50% of the cells were infected by the
lentivirus; insulin-producing b-cells express both red and blue
fluorescent proteins, while non-insulin-producing b-cells and
other types of cells express only blue fluorescent proteins. For all
cases, blue fluorescence did not decrease significantly during the
course of the experiments, showing that our heterologous gene
constructs were not silenced epigenetically. However, when b-cells
were cultured on a standard 2D uncoated culture plate surface, red
fluorescence decreased after 7 days (Figure 8b) and almost com-
pletely disappeared after 21 days (Figure 8c), suggesting that
cultured b-cells lost their function. In comparison, when cells were
culturedwithBeads1EphA/EphrinA1DCM,redfluorescencewas
still strongly visible after 7 and 21 days (Figure 8d and 8e).
Discussion
Both type 1 and type 2 diabetes are characterized by the loss or
dysfunctionofpancreaticb-cells
42.Therefore,theformationoffunc-
tional new b-cells is considered to be an ultimate cue for diabetes
therapy. Strategies for increasing the b-cell mass include inhibiting
b-cellapoptosisandstimulating b-cellreplication oforiginal cells,as
well as regeneration from embryonic stem/progenitor cells
42,43.I n
both cases, creating an ex vivo microenvironment for b-cells is crit-
ical to enhance their survival and maintain their phonotype.
Previous studies have demonstrated that cell–cell and cell–ECM
interactions are the important for the survival and function of pancre-
atic b-cells
7,12,16. The understanding of critical cell–cell and cell–ECM
interactions is the key to engineering biomimetic microenvironments
that can recapitulate the 3D organization of b-cells in the pancreatic
tissue. For in vitro cell culture, increasing cell-seeding density is a
common method to increase the possibility of cell-cell contact and
decreases the distance between cells to enhance paracrine signaling
18,44.
However, it is not practical due to the high cost for the isolation of
primary b-cells. As an alterative approach, cell-cell interactions were
Figure 4 | Characterization of PEG-co-PLL 1 DCM microbeads. (a) FT-IR spectra ofPEG-co-PLL 1 DCM microbeads, PEG-co-PLL microbeads, and
DCM. (b), (c) SEM images of lyophilized PEG-co-PLL and PEG-co-PLL 1 DCM microbeads, respectively. The insets high magnification images
show the surface morphologies of the microbeads. The scale bar of the inset images is 2 mm.
www.nature.com/scientificreports
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conjugated with cell surface receptors EphA and EphrinA
16. For cell-
ECM interactions, specific or combination of ECM proteins can be
selectively conjugated onto synthetic PEG hydrogels; as a result, they
have been widely used for the study of encapsulation of cells for
mimicking the cell-ECM interactions on promoting the survival of
pancreatic b-cells. Efforts include immobilization of glucagon- like
peptide 1 (GLP-1) to enhance b-cell encapsulation
20, modification of
Figure 6 | Size distribution of the aggregates formed by b-cells and with various types of PEG-co-PLL microbeads at day 21. The red lines indicate the
typical size distribution of those aggregates at day 7.
Figure 5 | Live/dead cell viability assay of pancreatic b-cells cultured with various PEG-co-PLL microbeads at day 7 andday 21. (a)Optical fluorescent
images of b cell cultured with various types of PEG-co-PLL microbeads. Cells cultured conventional polystyrene substrate was used as control
(non-coating). The cells were stained with calcein AM (green) and Ethidium homodimer-1 (red). (b) Quantitative analysis of live/dead cell viabilityo f
cellsculturedinthevarioustypesofmicrobeads.n54.Theerrorbarsrepresentthes.d.ofthreemeasurements.(c)Fluorescentimageofaggregationofb-
cells (green color) and the microbeads (dark color, indicated by the arrow) underneath the cells. The scale bar is 200 mm in a, and 100 mmi nc ,
respectively.
www.nature.com/scientificreports
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6, conjugation of affinity peptides
to sequester cytokine
45 to improve immunoisolation of hydrogels.
However, mostly of the findings from current work were carried
out from MIN6 insulinoma cell line, not from primary b-cells.
Furthermore, these hydrogel systems were not able to reconstruct
the native microenvironment of the pancreatic tissue-specific ECM.
How to enhance the survival and stability of primary b-cells remains
a critical challenge.
Recently, extensive efforts havecontributed tothe development of
decellularized tissue or organs, which have shown success in remov-
ing cellular components and preserving important components in
the ECM from heart, liver, muscle and other tissue
28,30–32. Similar to
those approaches, decellularized pancreatic tissue contains key ECM
components, which provides ‘‘pseudo-native’’ environment for in
vitro culture of b-cells. As the first step of this work, we optimized
a method to prepare DCM from pancreatic tissue. Specifically, The
Figure 8 | Population change of b-cells in 2D and 3D conditions. Fluorescent microscopy images of lentivirally infected b-cell and cell aggregates
culturedatnon-coating2Dsurface(aforafterinfection,bforday7andcforday21,respectively),andculturedwithBeads1EphA/EphrinA1DCM(d
for day 7and efor day 21, respectively). Cells were double infected with alentivirus encoding hIns(33)_mKate-2A-Puro that expresses ared fluorescent
protein mKate (along with translationally fused Puromycin resistance protein) depending on insulin promoter hIns(33) activity and a lentivirus
encoding hEF1a_EBFP2 that constitutively expresses blue fluorescent protein EBFP2 from hEF1a promoter. Puromycin selection was not used in this
experiment. Cells were cultured in a 48-well microplate, with approximately 6 3 10
4 cells/well initially. In the microbeads conditions, 3.6 3
10
5 microbeads/well were used. Insets show a zoom-in of representative cells, with a scale bar of 20 mm.
Figure 7 | Functionofb-cellsculturedinvariousconditions. (a)qPCRanalysisofb-cellspecificgene(MafA,Ins2andPdx1)expressionincellscultured
withvarioustypesofPEG-co-PLLmicrobeadsat21days.(b)Glucosestimulatedinsulinsecretion(GSIS)ofb-cellsculturedwithBeads1EphA/EphrinA
1 DCM or in 2D Non-coating (TCPS) surface. Cells were cultured in a 48-well microplate, with approximately 1.2 3 10
5 cells/well. In the microbead
containing conditions, 3.6 3 10
5 microbeads/well were used. n 5 4. The error bars represent the s.d. of three measurements.
www.nature.com/scientificreports
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ponents and disrupt nucleic acids, and the non-ionic detergent
Triton X-100 was used to disrupt lipid-lipid and lipid-protein inter-
actions, while leaving protein-protein interaction intact
27. After
decellularization, all residual chemicals are carefully removed to
avoidanyadversehosttissueresponsetothechemicals.Thesolution
of the digested pancreatic DCM is first tested on polystyrene sub-
strates. Rat primary b-cells cultured on a DCM modified substrate
showed improvements on cell viability and stability over two weeks
(unpublished results).
Then, EphA5–Fc and EphrinA5-FC modified PEG-co-PLL
microbeadswerepreparedfromdropletsgeneratedbyamicrofluidic
reactor. Positively charged PLL in the polymer network ensured
weak positive charges on the surfaces of the microbeads. Then a
solution of DCM with negatively charged ECM components was
absorbed onto the microbead surface and created a thin shell of
extracellular matrix, as confirmed by FT-IR results and SEM images
shown in Figure 4. When dispersed b-cells were cultured among
thesemicrobeadsincellmedia,cellsandbeadscreatedclose-packing
3D structures that include direct contact of cell-to-cell and cell-to-
ECM.
Several previous studies have shown that without cell–ECM inter-
actions, dissociated b-cells cannot survive when they are encapsu-
lated in synthetic hydrogels
20,46. G. C. Weir and colleagues have
demonstrated that small b-cell re-aggregates were able to survive
and function better than intact islets within alginate microcapsules,
mostly due to the fact of sufficient oxygen transport and enhanced
cell-cell contact
47. Recently, the Anseth group revealed a type of cell-
laden hydrogel that mimics the synergistic effect of cell-ECM and
cell-cell interactions, and the dissociated b-cells in the hydrogel can
surviveatdensitiesover1310
6 cells/mL
16.However,themajorityof
encapsulated b-cells underwent apoptosis in ten days, mostly due to
nonsufficient cell-ECM and cell-cell interactions. In our approach,
the presentation of b-cells in the microbeads mimicked the 3D
organization and aggregation of cells in the pancreatic islets. Cells
and microbeads were in close contact, which initiated the aggrega-
tion of cells with other beta cells and with microbeads. As shown in
Figure 5, cells were present in all four 3D conditions; and no signifi-
cant difference among them at day 7, suggested that aggregation (as
increasing the local cell-seeding density) of cells enhanced b-cell
survival by providing sufficient cell–cell interactions. This is in good
agreement with the work reported by previous researchers
18,47.W e
also found that the size and size distributions of the aggregates are
very similar in all four 3D conditions.
At day 21, b-cells cultured in the 3D synthetic ‘‘neighbor’’
microbeads structure had better viability as well. More importantly,
cells in the Beads 1 EphA/EphrinA 1 DCM condition had over five
fold higher viable cells comparing to cells on 2D surface, while other
3D conditions (Beads only, Beads 1 EphA/EphrinA, and Beads 1
DCM)alsoincreasethecellviability.Wefurthercheckedthesizeand
size distributions of the cell aggregates atday 21(shown in Figure 6).
ThebettersurvivalratefortheBeads1EphA/EphrinA1DCMcells
was most likely due to the larger sizes of the aggregates (fewer single
cells), and synergistic effects of both cell-to-cell and cell-to-ECM
interactions. Furthermore, we checked the expression of b-cell spe-
cific genes for the survivor cells at day 21, as shown in Figure 7a.
MafA, Ins2 and Pdx1 are typical genes that undergo downregulation
when b-cells lose their identity and insulin producing ability
48,49.
Compared to the cells on the 2D control surface, we observed 20–
70%upregulationof thosegenes forthecellscultured intheBeads 1
EphA/EphrinA 1 DCM condition, suggesting better b-cell function
for the cells in this 3D microenvironment. Downregulation of these
three genes for the other three 3D conditions (Beads only, Beads 1
EphA/EphrinA, and Beads 1 DCM) also indicated that some popu-
lations of survived cells lose the b-cell identity due to the lack of
above synergistic effects. Additionally, as shown in Figure 7(b), cells
cultured with Beads 1 EphA/EphrinA 1 DCM retained a positive
GSIS response, an indicator of proper b-cell function out to 21 days
inculture.Wealsodemonstratedsustainedinsulinpromoteractivity
in cells cultured with Beads 1 EphA/EphrinA 1 DCM over 21 days
whichwaslostincellsculturedin2DNon-coatingsurface(Figure8).
Our studies suggest that increased cell survival and function with
microbead-based microenvironment may be attributed to: (i)
increased local cell density for actual cell–cell contact, (ii) efficient
cell-cell and cell-ECM interactions between the beta cells and
microbead synthetic neigbors, (iii) ECM from native pancreatic tis-
sue,(iv)synergistic effectsofbothcell-to-cellandcell-to-ECM inter-
actions, and (v) elimination of mass transport limitations of oxygen
and nutrients in the 3D microenvironment.
In summary, we presented the approach of using close-packed
PEG-co-PLL microbeads to create a biomimetic 3D microenviron-
ment to improve the survival and function of primary pancreatic
b-cells. We demonstrated that selective modification of these
microbeadswithcellsurfacecadherinreceptorsandpancreatictissue
specific extracellular matrix can provide sufficient native-like cell-
cell and cell-ECM interactions, which initiate the formation of cell-
cell-bead aggregates and create synergistic effects for comprehensive
interactions between real b-cells and the microbeads (‘‘pseudo b-
cells’’). Primary pancreatic b-cells cultured in this platform had a
five-fold enhanced rate of survival and had significantly improved
expression of b-cell specific genes and glucose stimulated insulin
secretion for up to 21 days in culture.
Our microbead-based microenvironment provides a new method
to maintain primary b-cell phenotype and function in vitro for clin-
ical applications, which has been a long-standing obstacle for dia-
betes therapy. Following the dynamics of the decline in b-cell mass
might provide insight to the pathologic mechanisms of both Type 1
and Type 2 diabetes
50. This technique could be applied to evaluate
interventional efficacies as well as improving our understanding of
the effects of medication and glycemic control on b-cell mass. Our
approachalsoprovidesapossiblestrategyfordirectinginvitrob-cell
expansion by incorporating proper growth factors into the
microbead-based 3D culture system. Furthermore, taking advantage
of microfluidic synthetic techniques, polymer microbeads with con-
trolled physical, chemical and biological properties (i.e. size, shape,
stiffness, chemical composition, conjugation of different types of
bioactive ligands, etc.) can be easily achieved. Together with a tis-
sue-specific extracellular matrix, microbead-based cell culture plat-
forms can open a variety of opportunities for the study of complex
biological problems for other types of cells.
Methods
The preparation of decellularized matrix (DCM) and DCM coating solution. All
procedures were in compliance with the Federal Regulation on Animal Care and
Harvard Medical School animal use protocol, following all the ethical guidelines for
experimental animals. Maintenance of mouse colonies and all experiments were
conducted in accordance with the Guide for the Use and Care of Laboratory Animals
and approved by the Harvard Medical Area Standing Committee on Animals.
Pancreatictissuewasharvestedfromadultratsandperfused withD-PBS.Connective
tissue and fat was removed. The tissue was then cut into , 1c m
3 pieces, and
decellularized.Specifically,thetissuewasrinsedwithdeionizedwaterandthenstirred
in 1 wt% aqueous solution of Triton X-100 with 0.01 M ammonium hydroxide
(NH4
1OH
2) for 48 hours. The decellularized pancreatic tissue was rinsed with
deionized water to completely remove the detergent. A sample of decellularized
matrixwasfrozenandsectionedinto10 mmslices,andstainedwithhematoxylinand
eosin (H&E) to confirm the absence of cells. The decellularization tissue was
lyophilized for 48 hours and milled into fine-grained powder and stored at 220uC.
The milled powder of decellularized tissue was solubilized through enzymatic
digestion
29. Pepsin (SIGMA, St. Louis, MO) was dissolved in 0.01 M hydrochloric
acid (HCl) to make 1 mg/mL solution. Approximately 10 mg of the DCM was
digested in 1 mL of pepsin solution at 37uC under constant shaking. After 24 hours,
the pH of the digestion solution was adjusted to 7.4 with 0.1 M sodium hydroxide
(NaOH) solution and diluted with 10 3 D-PBS. The final concentration of DCM in
the PBS solution is 4 mg/mL.
Thiolation of receptors and preparation of PEG-co-PLL solutions. Free thiol
groups were introduced onto fusion proteins (EphA5–Fc, and EphrinA5–Fc) using
www.nature.com/scientificreports
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Anseth group
16. Specifically, fusion proteins were dissolved in PBS containing 2 mM
EDTA. Traut’s reagent (10 mM) was mixed with the fusion protein solution (2 mM
and reacted for 1 hour at room temperature. Excess Traut’s reagent was separated
from the thiolated proteins solution using a desalting column (Zeba
TM Spin, 40 K,
ThermoFisher Scientific). The pre-gel aqueous solution comprises the following
ingredients: 8 wt% poly(ethylene glycol) dimethylacrylate (PEGDMA: Mw 5 1000,
Polyscience), 2 mg/mL poly-L-lysine hydrobromide (PLL, Mw 5 15,000 , 30,000),
0.2 mM thiolated EphA5-FC and EphrinA5-Fc, and 0.5 wt% of photo-initiator 2-
hydroxy-2-methylpropiophenone (HMPP).
Microfluidic synthesis of PEG-co-PLL microbeads and surface modification.
MastersforpreparingmicrofluidicreactorwerepreparedwithanSU-8photoresistin
bas-relief on silicon wafers. The microfluidic device was fabricated in
poly(dimethylsiloxane) (PDMS) by using a standard soft-lithography method
51.T h e
thickness of the microochanel is approximately 80 mm. PEG-co-PLL microbeads
with mono-dispersed size distribution were carried out in the microfluidic
reactors
35,52. Briefly, two immiscible liquids, an aqueous PEG-co-PLL pre-gel
solution, and a mineral oil solution with 2 wt% surfactant Span80 and 0.5 wt%
photo-initiator HMPP were supplied to the microchannels using two digitally
controlled syringe pumps (Harvard Apparatus PHD 2000, U.S.A.). After
emulsification, the PEG-co-PLL droplets were flowed in extension tubing and
exposed to UV irradiation for 5 minutes. A Zeiss Axioskop 2 optical and fluorescent
microscope and a high-speed digital camera were used to acquire images. Various
flow rates of oil phase and pre-gel phase were used to prepare microbeads with
designed sizes. After polymerization, the microbeads were separated from oil phase
by centrifugation (1500 rpm, 5 minutes), washed with 0.2 wt% of Triton X-100
aqueous solution, then washed with DI water to remove oil, surfactant and other
residues. To modify the microbeads with DCM, the beads were added into 4 wt%
DCM solution and incubated at 37uC for four hours. Then the microbeads were
washed with cell media for several times and stored in cell media for future use. The
monodispersity of the microbeads was defined as standard deviation divided by the
mean size.
Characterization of PEG-co-PLL microbeads. PEG-co-PLL and PEG-co-PLL 1
DCMmicrobeads werelyophilized for 72 hours. Thechemical compositions ofthese
microbeads were analyzed by Fourier-transform infrared (FT-IR) (Nexus 870,
Thermo Scientific) spectroscopy for the dry beads. Scanning electron microscopy
(SEM)(JEOLJSM-6060) wasalsousedtovisualize thesurface morphologyofthe dry
microbeads.
Cell culture and characterization of DCM. Rat pancreatic islets were isolated as
previous described
53, then the islets were dissociated into single cell mixture (mostly
b-cells) using 0.05% trypsin EDTA solution
16, and no further purification was
performed.ThecellmediaislowglucoseDMEMmediumcontaining2%fetalbovine
serum (FBS), 1% penicillin-streptomycin. Medium was changed every 2–3 days.
Typically, cells with microbeads were cultured in a 48-well microplate (BD
Biosciences, San Jose, CA), with approximately 1.2 3 10
5 cells/well and 3.6 3
10
5 microbeads/well. We generated four types of microbeads, specifically, PEG-co-
PLL microbeads (Beads only), EphA/EphrinA fusion protein modified PEG-co-PLL
microbeads (Beads 1 EphA/EphrinA), PEG-co-PLL microbeads absorbed with
DCM (Beads 1 DCM), and EphA/EphrinA fusion protein modified PEG-co-PLL
microbeads absorbed with DCM (Beads 1 EphA/EphrinA 1 DCM). Cells cultured
without microbeads in the microwells were used as a control (non-coating).
Solubilized DCM was analyzed by SDS-PAGE and compared to lysed pancreatic
tissue. Solutions were run on a Tris–HCl, 12% polyacrylamide gel (Bio-Rad
Laboratories, Inc, Hercules, CA) in Tris/Glycine/SDS buffer (Fisher Scientific Inc,
Hanover Park, IL), with 80 mM reducing agent Dithiothreitol (DTT) (Invitrogen,
Carlsbad, CA). Gel electrophoresis was performed in an XCell Surelock MiniCell
(Invitrogen), compared to a broad range standard, and stained with Imperial Protein
Stain (Pierce, Rockford, IL).
Cell viability in various types of microbeads. Cell viability was determined using a
LIVE/DEADH viability kit. Cells cultured with various types of mirobeads were
placed in D-PBS containing calcium AM and ethidium homodimer according to
manufacturer’s staining protocol for at least 45 minutes. Briefly, live/dead cells are
distinguished by intracellular esterase activity, which was determined by the
enzymatic conversion of the virtually nonfluorescent dye calcein AM to the
fluorescent calcein. The polyanionic dye calcein was retained within live cells,
producing an intense uniform green fluorescence in live cells (ex/em , 495 nm/
,515 nm). EthD-1 enters cells with damaged membranes and undergoes a 40-fold
enhancement of fluorescence upon binding to nucleic acids, thereby producing a
bright red fluorescence in dead cells (ex/em , 495 nm/,635 nm). EthD-1 is
excluded by the intact plasma membrane of live cells.
Analysis of the size of cell-cell-beads aggregates. The size and size distributions of
the aggregates formed by b-cells and various types of microbeads were quantified by
usingImageJ.Briefly, theflorescent images takenfromthe Live/DeadHviabilityassay
were split into green and red channels, and only the live cells and aggregates in the
green channel were analyzed. The images were converted to threshold format to
count the numbers and determine the area of the cells and aggregates by the software
ImageJ. We defined three groups of size ranges as 1–100, 100–400, and . 400 mm
2,
representing single cell, small aggregates, and large aggregates, respectively.
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